Novo Nordisk is set to launch Ozempic, its oral GLP-1 receptor agonist pill for adults with type 2 diabetes, in the US.

Eli Lilly is a leader in one of today’s biggest growth markets: weight loss drugs. The company recently won approval for an ...

The National Psoriasis Foundation has issued a detailed primer supporting GLP-1 receptor agonists as an adjunct therapy for psoriasis in patients with metabolic comorbidities. Evidence shows these ...

People taking semaglutide, the active ingredient in Ozempic and Wegovy, were 44% less likely to be treated for depression and ...

Ashley Graham criticises GLP-1 drugs and Ozempic trend, calling it a 'smack in the face' to body positivity in Hollywood and fashion.

A Gujarat man’s unsupervised semaglutide use led to medullary thyroid cancer, highlighting the dangers of weight-loss ...

Ireland's GDP soared 12.3% in 2025 — but it was a mirage. Pharma multinationals front-loaded €25.4bn of exports to the US in ...

Ashley Graham is not happy with what the prevalence of GLP-1 drugs is doing to body positivity. The popular plus-size model is the cover star of Marie Claire’s latest Motherhood Issue, and she ...

GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and ...

Experts have discovered a surprising new health benefit of weight-loss medication – among people who haven’t even taken it.

Ozempic breath,” which got the moniker from the GLP-1 causing bad breath, has made mints and gum a premium product.